Enteric fever, a systemic illness primarily caused by Salmonella Typhi and Salmonella Paratyphi, poses significant challenges in clinical practice due to its complex presentation and increasing antimicrobial resistance. This article outlines effective strategies for managing enteric fever.
Early recognition of enteric fever is crucial for prompt treatment. Clinicians should maintain a high index of suspicion in patients presenting with high-grade fever, relative bradycardia, and abdominal discomfort, particularly in endemic areas or in those with a history of recent travel to such regions.
Reliable diagnostic tests are essential for confirming enteric fever. Blood cultures remain the gold standard, with sensitivity rates of 40-60%. However, serological tests like Widal and Typhidot can be useful in resource-limited settings. Molecular methods such as PCR are emerging as promising tools for early diagnosis.
Choosing the right antimicrobial therapy is critical in managing enteric fever. Empirical therapy should be guided by local antibiotic resistance patterns. Fluoroquinolones, third-generation cephalosporins, and azithromycin are commonly used. However, the emergence of extensively drug-resistant (XDR) strains necessitates regular antimicrobial susceptibility testing.
Vaccination against typhoid is an effective preventive measure, especially in endemic areas. Two vaccines, Vi polysaccharide and Ty21a, are currently available. Moreover, improving sanitation and promoting safe food and water practices can significantly reduce the incidence of enteric fever.
Managing enteric fever effectively requires a comprehensive approach that includes early recognition, accurate diagnosis, appropriate antimicrobial therapy, and preventive measures. As the landscape of enteric fever continues to evolve with increasing antimicrobial resistance, clinicians must stay updated on the latest research and guidelines to provide optimal care to their patients.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation